INTEST CORP·4

Mar 18, 5:03 PM ET

Gilmour Duncan 4

4 · INTEST CORP · Filed Mar 18, 2026

Research Summary

AI-generated summary of this filing

Updated

InTest (INTT) CFO Gilmour Duncan Receives Restricted Shares & Option

What Happened

  • Gilmour Duncan, Chief Financial Officer, Treasurer and Secretary of InTest Corporation (INTT), was granted equity awards on March 16, 2026 totaling 21,256 shares: two restricted stock awards of 5,760 shares each and a derivative award of 9,736 shares. All were granted at $0 (i.e., awards, not purchases), so no cash was paid for the shares/options at grant.
  • These awards are compensation grants (not open-market purchases or sales) and are intended to vest over future periods per the company’s 2023 Stock Incentive Plan.

Key Details

  • Transaction date: 2026-03-16. Filing date: 2026-03-18 (report filed timely).
  • Grants shown: 5,760 shares (restricted) + 5,760 shares (restricted) + 9,736 (derivative/option) = 21,256 total.
  • Price: $0.00 per share (award/grant).
  • Footnote summaries from the filing:
    • F1: Restricted shares granted under the 2023 Stock Incentive Plan; vest in four equal annual installments beginning March 16, 2027.
    • F2: Performance-based restricted shares granted under the Plan; vest in March 2029 if performance targets are met. The amount shown is the target; maximum possible vesting is 8,640 shares.
    • F3: Option granted under the Plan; vests in four equal annual installments beginning March 16, 2027.
  • Shares owned after the transactions are not disclosed in the provided excerpt of the filing.
  • Transaction exempt status: grants were made in a transaction exempt under Rule 16b-3 (typical for compensatory grants to insiders).

Context

  • These are compensatory awards, not sales or open-market purchases; they generally reflect standard equity-based pay and will be subject to vesting and (for the performance shares) performance conditions before the insider can realize value.
  • The derivative entry represents an equity award/option subject to time-based vesting (not a cashless exercise or immediate sale). Performance-based awards can result in fewer or more shares vesting depending on outcomes (the filing shows target and the stated maximum).

Insider Transaction Report

Form 4
Period: 2026-03-16
Gilmour Duncan
CFO, Treasurer & Secretary
Transactions
  • Award

    Common Stock

    [F1]
    2026-03-16+5,76062,194 total
  • Award

    Common Stock

    [F2]
    2026-03-16+5,76067,954 total
  • Award

    Employee Stock Option (right to buy)

    [F3]
    2026-03-16+9,7369,736 total
    Exercise: $14.47Exp: 2036-03-15Common Stock (9,736 underlying)
Holdings
  • Common stock

    (indirect: By Spouse)
    200
  • Employee Stock Option (right to buy)

    [F4]
    Exercise: $7.74Exp: 2035-03-16Common Stock (1,992 underlying)
    1,992
  • Employee Stock Option (right to buy)

    [F4]
    Exercise: $7.74Exp: 2035-03-16Common Stock (18,077 underlying)
    18,077
  • Employee Stock Option (right to buy)

    [F5]
    Exercise: $11.33Exp: 2034-03-05Common Stock (12,724 underlying)
    12,724
  • Employee Stock Option (right to buy)

    [F6]
    Exercise: $16.06Exp: 2033-03-07Common Stock (8,044 underlying)
    8,044
  • Employee Stock Option (right to buy)

    [F7]
    Exercise: $9.76Exp: 2032-03-08Common Stock (12,848 underlying)
    12,848
  • Employee Stock Option (right to buy)

    [F7]
    Exercise: $16.80Exp: 2031-06-13Common Stock (8,104 underlying)
    8,104
Footnotes (7)
  • [F1]These restricted shares were granted pursuant to the InTest Corporation 2023 Stock Incentive Plan (the "Plan") in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 16, 2027.
  • [F2]These performance-based restricted shares were granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest in March 2029 dependent upon certain performance criteria. The amount shown reflects the number of shares that will vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 8,640.
  • [F3]This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 16, 2027.
  • [F4]This option vests in four equal annual installments commencing on March 17, 2026.
  • [F5]This option vests in four equal annual installments commencing on March 6, 2025.
  • [F6]This option vests in four equal annual installments commencing on March 8, 2024.
  • [F7]This option is fully vested as of the date of this report.
Signature
/s/ Duncan Gilmour|2026-03-18

Documents

2 files
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

  • EX-24.1

    GILMOUR POA